Angiotensin-converting enzyme inhibition and blood pressure response during total intravenous anaesthesia for minor surgery

Acta Anaesthesiologica Scandinavica

Volumn 55, Issue 4, 2011, Pages 435-443

  Schulte, Erika ^a   Ziegler, D ^b   Philippi Hohne C ^c   Kaczmarczyk, G ^a   Boemke, W ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Klinik Nauen   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CAPTOPRIL; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; INFUSION FLUID; LISINOPRIL; NORADRENALIN; PERINDOPRIL; PROPOFOL; RAMIPRIL; REMIFENTANIL; RENIN; VASOCONSTRICTOR AGENT; VASOPRESSIN;

AGED; ANESTHESIA INDUCTION; ARTICLE; BLOOD PRESSURE REGULATION; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; ENZYME INHIBITION; FEMALE; HEART RATE; HORMONE BLOOD LEVEL; HUMAN; INTRAVENOUS ANESTHESIA; MALE; MEAN ARTERIAL PRESSURE; MINOR SURGERY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

AGED; ANESTHESIA, INTRAVENOUS; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CATECHOLAMINES; FEMALE; FLUID THERAPY; HEART RATE; HUMANS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; PROSPECTIVE STUDIES; RENIN; RENIN-ANGIOTENSIN SYSTEM; SAMPLE SIZE; SURGICAL PROCEDURES, MINOR; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 79952607637     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2011.02409.x     Document Type: Article

References (32)

1. Behnia R, Molteni A, Igić R. Angiotensin-converting enzyme inhibitors: mechanisms of action and implications in anaesthesia practice. Curr Pharm Des 2003; 9: 763-76. (Pubitemid 36367597)
2. Colson P, Ryckwaert F, Coriat P. Renin angiotensin system antagonists and anaesthesia. Anesth Analg 1999; 89: 1143-55. (Pubitemid 29521929)
3. Colson P, Saussine M, Séguin JR, Cuchet D, Chaptal P-A, Roquefeuil B. Hemodynamic effects of anaesthesia in patients chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 1992; 74: 805-8.
4. Kataja JH, Kaukinen S, Viinamäki OV, Metsä-Ketelä TJ, Vapaatalo H. Hemodynamic and hormonal changes in patients pretreated with captopril for surgery of the abdominal aorta. J Cardiothorac Anesth 1989; 3: 425-32. (Pubitemid 19216451)
5. Ryckwaert F, Colson P. Hemodynamic effects of anaesthesia in patients with ischemic heart failure chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 1997; 84: 945-9. (Pubitemid 27197648)
6. Licker M, Neidhart P, Lustenberger S, Valloton MB, Kalonji T, Fathi M, Morel DR. Long-term angiotensin-converting enzyme inhibitor treatment attenuates adrenergic responsiveness without altering hemodynamic control in patients undergoing cardiac surgery. Anesthesiology 1996; 84: 789-800. (Pubitemid 26105241)
7. Ryckwaert F, Colson P, Ribstein J, Boccara G, Guillon G. Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction. Br J Anaesth 2001; 86: 169-75. (Pubitemid 32103403)
8. Schuetz WH, Lindner KH, Georgieff M, Mueller S, Oertel F, Radermacher P, Gauss A. The effect of i.v. enalaprilat in chronically treated hypertensive patients during cardiac surgery. Acta Anaesthesiol Scand 1998; 42: 929-35. (Pubitemid 28416863)
9. Wagner F, Yeter R, Bisson S, Siniawski H, Hetzer R. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction. Crit Care Med 2003; 31: 1421-8. (Pubitemid 36583854)
10. Bertrand M, Godet G, Meersschaert K, Brun L, Salcedo E, Coriat P. Should the angiotensin II antagonist be discontinued before surgery? Anesth Analg 2001; 92: 26-30.
11. Brabant SM, Bertrand M, Eyraud D, Darmon PL, Coriat P. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg 1999; 88: 1388-92.
12. Oh YJ, Lee JH, Nam SB, Shim JK, Song JH, Kwak YL. Effects of chronic angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitor treatments on neurohormonal levels and haemodynamics during cardiopulmonary bypass. Br J Anaesth 2006; 97: 792-98. (Pubitemid 44823663)
13. Comfere T, Sprung J, Kumar MM, Draper M, Wilson DP, Williams BA, Danielson DR, Liedl L, Warner DO. Angiotensin system inhibitors in a general surgical population. Anesth Analg 2005; 100: 636-44. (Pubitemid 40300051)
14. Ledowski T, Bein B, Hanss R, Paris A, FudickarW, Scholz J, Tonner PH. Neuroendocrine stress response and heart rate variability: a comparison of total intravenous versus balanced anesthesia. Anesth Analg 2005; 101: 1700-5. (Pubitemid 41720623)
15. Coriat P, Richer C, Douraki T, Gomez C, Hendricks K, Guidicelli J-F, Viar P. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 1994; 81: 299-307. (Pubitemid 24320619)
16. Schirmer U, Schürmann W. Zur perioperativen Gabe von ACE-Hemmern. Anaesthesist 2007; 56: 557-61. (Pubitemid 46985727)
17. Raja SG, Fida N. Should angiotensin converting enzyme inhibitors/angiotensin II receptor antagonists be omitted before cardiac surgery to avoid postoperative vasodilatation? Interact Cardiovasc Thorac Surg 2008; 7: 470-5.
18. Kugler J. Elektroenzephalographie in Klinik und Praxis. Stuttgart, New York: Thieme, 1981.
19. Schultz B, Schultz A, Grouven U. Sleeping stage based systems (Narcotrend). In: Bruck HP, Koeckerling F, Bouchard F, Schug-Pass C., eds. New aspects of high technology in medicine 2000. Bolognia: Monduzzi Editore, 2000:285-91.
20. Schultz B, Grouven U, Schultz A. Automatic classification algorithms of the EEG monitor Narcotrend for routinely recorded EEG data from general anaesthesia. A validation study. Biomed Tech 2002; 47: 9-13. (Pubitemid 34219542)
21. Fischler MP, Follath F. Vergleichende Evaluation der ACE-Hemmer: Welche Unterschiede sind relevant? Schweiz Med Wochenschr 1999; 129: 1053-60.
22. Seitz W, Lübbe N, Schaps D, Haverich A, Kirchner E. Propofol zur Einleitung und Aufrechterhaltung der Hypnose bei koronarchirurgischen Eingriffen: Ergebnisse humanpharmakologischer Untersuchungen. Anaesthesist 1991; 40: 145-52 (in German).
23. Maguire AM, Kumar N, Parker JL, Rowbotham DJ, Thompson JP. Comparison of effects of remifentanil and alfentanil on cardiovascular response to tracheal intubation in hypertensive patients. Br J Anaesth 2001; 86: 90-3. (Pubitemid 32014128)
24. Höhne C, Meier L, Boemke W, Kaczmarczyk G. ACE inhibition does not exaggerate the blood pressure decrease in the early phase of spinal anaesthesia. Acta Anaesthesiol Scand 2003; 47: 891-6. (Pubitemid 36898038)
25. Schunkert H, Ingelfinger JR, Hirsch AT, Pinto Y, Remme WJ, Jacob H, Dzau VJ. Feedback regulation of angiotensin-converting enzyme activity and mRNA levels by angiotensin II. Circ Res 1993; 72: 312-8. (Pubitemid 23024519)
26. Wolny A, Clozel JP, Rein J, Mory P, Vogt P, Turino M, Kiowski W, Fischli W. Functional and biochemical analysis of angiotensin II forming pathways in the human heart. Circ Res 1997; 80: 219-27. (Pubitemid 27056985)
27. Goldmann A, Höhne C, Fritz GA, Unger J, Ahlers O, Nachtigall I, BoemkeW. Combined vs. Isoflurane/Fentanyl anesthesia for major abdominal surgery: effects on hormones and hemodynamics. Med Sci Monit 2008; 14: 445-52.
28. Brockmann C, Raasch W, Bastian C. Verhalten endokriner Stressparameter bei remifentanil-oder sufentanilgestützter TIVA. Anästhesiol Intensivmed Notfallmed Schmerzther 2000; 35: 685-91.
29. Marana E, Scambia G, Colicci S, Maviglia R, Maussier ML, Marana R, Proietti R. Leptin and perioperative neuroendocrine stress response with two different anaesthetic techniques. Acta Anaesthesiol Scand 2008; 52: 541-6. (Pubitemid 351392866)
30. Malinowska-Zaprzalka M, Wojewodzka M, Dryl D, Grabowska SZ, Chabielska E. Hemodynamic effect of propofol in enalapril-treated hypertensive patients during induction of general anaesthesia. Pharmacol Rep 2005; 57: 675-8.
31. Makris R, Coriat P. Interactions between cardiovascular treatments and anaesthesia. Curr Opin Anaesthesiol 2001; 14: 33-9. (Pubitemid 32113150)
32. Taffé P, Sicard N, Pittet V, Pichard S, Burnand B. The occurrence of intra-operative hypotension varies between hospitals: observational analysis of more than 147,000 anaesthesias. Acta Anaesthesiol Scand 2009; 53: 995-1005.